经皮心室辅助装置在复杂高危冠状动脉介入治疗中的应用进展  

Application Progress of Percutaneous Ventricular Assist Device in Complex High-Risk Coronary Intervention

作　　者：管翔 王宇[2] 张成糕 周健 张艺 李庆国[1] GUAN Xiang;WANG Yu;ZHANG Chenggao;ZHOU Jian;ZHANG Yi;LI Qingguo(Cardiovascular Center,The Second Affiliated Hospital of Nanjing Medical University,Nanjing 210011,Jiangsu,China;College of Automation,Nanjing University of Aeronautics and Astronautics,Nanjing 210000,Jiangsu,China)

机构地区：[1]南京医科大学第二附属医院心血管中心,江苏南京210011 [2]南京航空航天大学自动化学院,江苏南京210000

出　　处：《心血管病学进展》2022年第5期394-398,共5页Advances in Cardiovascular Diseases

基　　金：国家自然科学基金面上项目(82170503);江苏省重点研发技术(社会发展)(BE2021749)。

摘　　要：经皮冠状动脉介入治疗(PCI)技术的进展使得过去无法接受干预的复杂高危冠心病患者能够进行血运重建,但PCI过程可能对患者血流动力学造成不良影响,加重心功能不全。经皮心室辅助装置能在PCI过程中提供稳定的血流动力学保障,提高血运重建的安全性,因此经皮心室辅助装置作为复杂高危PCI的辅助手段可能是改善临床结果的关键。心室内轴流泵(Impella)系统、体外离心泵(TandemHeart)系统和体外膜氧合是当前较为新颖的经皮心室辅助装置,现就上述设备在复杂高危PCI中的应用现状和进展进行综述。Advances in percutaneous coronary intervention(PCI)technology have enabled revascularization in patients with complex high-risk coronary artery atherosclerotic heart disease who were previously unable to undergo intervention.However,the PCI procedure may adversely affect the patient’s hemodynamics and exacerbate cardiac insufficiency.The percutaneous ventricular assist device(pVAD)can provide stable hemodynamic guarantee during PCI and improve the safety of revascularization.Therefore,as an auxiliary means of complex high-risk PCI,pVAD may be the key to improve clinical results.Intraventricular axial flow pump(Impella)system,extracorporeal centrifugal pump(TandemHeart)system and extracorporeal membrane oxygenation are relatively novel percutaneous ventricular assist devices.This article reviews the application and development of these devices in complex high-risk PCI.

关 键 词：经皮心室辅助装置 经皮冠状动脉介入治疗 IMPELLA TandemHeart 体外膜氧合 

分 类 号：R54[医药卫生—心血管疾病]